Multiple studies have found a positive correlation between IL-10 levels and poor prognosis in various cancers, including melanoma, lung cancer, and T/NK-cell lymphomas (Boulland et al., 1998; Boyano et al., 2000; Li et al., 2014). This evidence concerns the gene IL10 and lung carcinoma.